Comparative activity of 27 antimicrobial compounds against 698 Streptococcus pneumoniae isolates originating from 20 European university hospitals

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 6, 1999, Pages 450-453

  Schmitz, F J ^a,b   Verhoef, J ^a   Fluit, A C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFACLOR; CEFADROXIL; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFPODOXIME; CEFPROZIL; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN G; RIFAMPICIN; SPARFLOXACIN; TETRACYCLINE; TROVAFLOXACIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; EUROPE; HOSPITALS, UNIVERSITY; HUMANS; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PENICILLINS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0032736610     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050318     Document Type: Article

References (12)

1. 1. Tomasz A: Antibiotic resistance in Streptococcus pneumoniae. Clinical Infectious Diseases (1997) 24, Supplement 1:85-88
2. 2. Baquero F: Pneumococcal resistance to β-lactam antibiotics: a global geographic overview. Microbial Drug Resistance (1995) 1:115-120
3. 3. Doern GV, Brueggeman A, Holley HP Jr, Rauch AM: Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995:results of a 30-center national surveillance study. Antimicrobial Agents and Chemotherapy (1996) 40:1208-1213
4. 4. Goldstein FW, Acar JF, and the Alexander Project Collaborative Group: Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 Western Europe and USA collaborative surveillance study. Journal of Antimicrobial Chemotherapy (1996) 38, Supplement A: 71-84
5. 5. Schmitz FJ, Verhoef J, Fluit AC, and the SENTRY Participants Group: Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY antimicrobial surveillance programme. European Journal of Clinical Microbiology & Infectious Diseases (1999) 17:414-421
6. 6. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial tests for bacteria that grow aerobically. Approved standard M7-A4. NCCLS, Wayne, PA (1997)
7. 7. Baquero F, Barrett JF, Courvalin P, Morrissey I, Piddock L, Novick WJ: Epidemiology and mechanisms of resistance among respiratory tract pathogens. Clinical Microbiology and Infection (1998) 4, Supplement 2:19-26
8. 8. Goldstein FW, Garau J: 30 years of penicillin-resistant Streptococcus pneumoniae: myth or reality? Lancet (1997) 350:233-234
9. 9. Sicard M, Selakovitch CL, Gianmarinaro P, Geslin P, Gasc AM: Genetic studies of cefotaxime resistance in Streptococcus pneumoniae. Advances in Experimental Medicine and Biology (1997) 418:429-433
10. 10. Figueiredo AM, Connor SJD, Severin A, Vitoria M, Pato V, Tomasz A: A pneumococcal isolate with high-level resistance to cefotaxime and ceftriaxone. Antimicrobial Agents and Chemotherapy (1992) 36:886-889
11. 11. Tait-Kamradt A, Clancy J, Cronan M, Dib-Hajj F, Wondrack L, Yuan W, Sutcliffe J: mefE is necessary for the erythromycin resistant M-phenotype in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy (1997) 41:2251-2255
12. 12. Schito GC, Manelli S, Pesce A and the Alexander Project Group: Trends in the activity of macrolide and β-lactam antibiotics and resistance development. Journal of Chemotherapy (1997) 9, Supplement 3:18-29